Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;39 Suppl 1(Suppl 1):i70-4.
doi: 10.1093/ije/dyq024.

Antibiotics for the treatment of dysentery in children

Beatrix S Traa  1 , Christa L Fischer Walker, Melinda Munos, Robert E Black
Affiliations
Review

Antibiotics for the treatment of dysentery in children

Beatrix S Traa et al. Int J Epidemiol. 2010 Apr.

Abstract

Background: Ciprofloxacin, ceftriaxone and pivmecillinam are the antibiotics currently recommended by the World Health Organization (WHO) for the treatment of dysentery in children; yet there have been no reviews of the clinical effectiveness of these antibiotics in recent years.

Methods: We reviewed all literature reporting the effect of ciprofloxacin, ceftriaxone and pivmecillinam for the treatment of dysentery in children in the developing countries. We used a standardized abstraction and grading format and performed meta-analyses to determine the effect of treatment with these antibiotics on rates of treatment failure, bacteriological failure and bacteriological relapse. The CHERG Standard Rules were applied to determine the final effect of treatment with these antibiotics on diarrhoea mortality.

Results: Eight papers were selected for abstraction. Treatment with ciprofloxacin, ceftriaxone or pivmecillinam resulted in a cure rate of >99% while assessing clinical failure, bacteriological failure and bacteriological relapse.

Conclusions: The antibiotics recommended by the WHO--ciprofloxacin, ceftriaxone and pivmecillinam--are effective in reducing the clinical and bacteriological signs and symptoms of dysentery and thus can be expected to decrease diarrhoea mortality attributable to dysentery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Synthesis of study identification to review effect of ciprofloxacin, ceftriaxone and pivmecillinam on diarrhoea treatment failure, bacteriological failure and bacteriological relapse
Figure 2
Figure 2
Application of the CHERG Guidelines for the effect of antibiotics on dystenteric morbidity and mortality
See this image and copyright information in PMC

References

    1. Guerin PJ, Brasher C, Baron E, et al. Case management of a multidrug-resistant Shigella dysenteriae serotype 1 outbreak in a crisis context in Sierra Leone, 1999–2000. Trans R Soc Trop Med Hyg. 2004;98:635–43. - PubMed
    1. Amieva MR. Important bacterial gastrointestinal pathogens in children: a pathogenesis perspective. Pediatr Clin North Am. 2005;52:749–77, vi. - PubMed
    1. Huppertz HI. An epidemic of bacillary dysentery in western Rwanda 1981–1982. Cent Afr J Med. 1986;32:79–82. - PubMed
    1. el Bushra HE, Bin Saeed AA. Intrafamilial person-to-person spread of bacillary dysentery due to Shigella dysenteriae in southwestern Saudi Arabia. East Afr Med J. 1999;76:255–59. - PubMed
    1. Kabir I, Butler T, Khanam A. Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial. Antimicrob Agents Chemother. 1986;29:645–48. - PMC - PubMed